Completed OBSERVATIONAL NCT01126554

ICG- Liver Test Versus New Biomarkers as Prognostic Markers in Critically Ill Patients (Greenpep)

ICG- Liver Test Versus New Biomarkers as Prognostic Markers in Critically Ill

Sponsor: Brahms AG

Updated 6 times since 2017 Last updated: Apr 28, 2014 Started: Jul 31, 2010 Primary completion: Dec 31, 2010 Completion: Feb 28, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Critically Ill and is currently completed. Brahms AG leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Study Description(click to expand)

Comparison of different marker for length of stay in the ICU in critically ill patients.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brahms AG
University of Zurich

Data source: University of Zurich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zurich, Switzerland